{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:42:47Z","timestamp":1756190567798},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbcan.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T03:30:44Z","timestamp":1496028644000},"page":"273-276","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression"],"prefix":"10.1016","volume":"1868","author":[{"given":"Haidn","family":"Foster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya V.","family":"Ulasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles S.","family":"Cobbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2017.05.006_bb0005","series-title":"International Agency for Research on Cancer, World Health Organization, World Cancer Report 2014","author":"Stewart","year":"2014"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-12-3002","article-title":"The definition of primary and secondary glioblastoma","volume":"19","author":"Ohgaki","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-016-2347-y","article-title":"Management of GBM: a problem of local recurrence","author":"Kirkpatrick","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0025","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988\u20132004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0030","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1099\/vir.0.81891-0","article-title":"Latency and reactivation of human cytomegalovirus","volume":"87","author":"Sinclair","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"Pt 4","key":"10.1016\/j.bbcan.2017.05.006_bb0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1099\/0022-1317-76-4-741","article-title":"Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues","volume":"76","author":"Sinzger","year":"1995","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0040","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0140-6736(02)11524-8","article-title":"Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer","volume":"360","author":"Harkins","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3835(03)00269-6","article-title":"Human herpes viruses in non-melanoma skin cancers","volume":"198","author":"Zafiropoulos","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0050","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.ju.0000080263.46164.97","article-title":"High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma","volume":"170","author":"Samanta","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0055","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/nan.12172","article-title":"Human cytomegalovirus and primary intracranial tumours: frequency of tumour infection and lack of correlation with systemic immune anti-viral responses","volume":"41","author":"Bianchi","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0060","first-page":"3347","article-title":"Human cytomegalovirus infection and expression in human malignant glioma","volume":"62","author":"Cobbs","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11060-010-0383-6","article-title":"The detection of CMV pp65 and IE1 in glioblastoma multiforme","volume":"103","author":"Lucas","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2042-4280-3-3","article-title":"Low levels of human cytomegalovirus infection in glioblastoma multiforme associates with patient survival; -a case-control study","volume":"3","author":"Rahbar","year":"2012","journal-title":"Herpesviridae"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00401-008-0359-1","article-title":"Detection of human cytomegalovirus in different histological types of gliomas","volume":"116","author":"Scheurer","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcv.2012.12.018","article-title":"Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival","volume":"57","author":"Rahbar","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1215\/15228517-2007-035","article-title":"Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma","volume":"10","author":"Mitchell","year":"2008","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40478-016-0338-z","article-title":"A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus - tumor association","volume":"4","author":"Strong","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0095","article-title":"Absence of cytomegalovirus in glioblastoma and other high-grade gliomas by real-time PCR, immunohistochemistry, and in situ hybridization","author":"Holdhoff","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0100","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/neuonc\/nou167","article-title":"Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics","volume":"16","author":"Baumgarten","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0105","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/neuonc\/nou295","article-title":"Response to \u201chuman cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics\u201d","volume":"16","author":"Cobbs","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0110","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-62703-788-4_11","article-title":"Methods for the detection of cytomegalovirus in glioblastoma cells and tissues","volume":"1119","author":"Cobbs","year":"2014","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0115","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMc0804818","article-title":"Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate","volume":"359","author":"Prins","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0120","doi-asserted-by":"crossref","first-page":"25989","DOI":"10.18632\/oncotarget.11175","article-title":"CMV70-3P miRNA contributes to the CMV mediated glioma stemness and represents a target for glioma experimental therapy","volume":"8","author":"Ulasov","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0125","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","article-title":"Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2","volume":"77","author":"Compton","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5732\/cjc.011.10236","article-title":"Platelet-derived growth factor receptor alpha in glioma: a bad seed","volume":"30","author":"Liu","year":"2011","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002905","article-title":"PDGF receptor-alpha does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway","volume":"8","author":"Vanarsdall","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature07209","article-title":"Platelet-derived growth factor-alpha receptor activation is required for human cytomegalovirus infection","volume":"455","author":"Soroceanu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0145","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1128\/JVI.75.13.6022-6032.2001","article-title":"Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling","volume":"75","author":"Johnson","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s00432-017-2415-5","article-title":"Combinatorial therapy with adenoviral-mediated PTEN and a PI3K inhibitor suppresses malignant glioma cell growth in vitro and in vivo by regulating the PI3K\/AKT signaling pathway","author":"Nan","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuron.2006.06.012","article-title":"PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling","volume":"51","author":"Jackson","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0160","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1172\/JCI116035","article-title":"Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages","volume":"90","author":"Smith","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.02.013","article-title":"Smoldering and polarized inflammation in the initiation and promotion of malignant disease","volume":"7","author":"Balkwill","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0170","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.canlet.2008.03.028","article-title":"Cancer related inflammation: the macrophage connection","volume":"267","author":"Sica","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0175","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0180","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1158\/1078-0432.CCR-11-0414","article-title":"Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype","volume":"17","author":"Dziurzynski","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0185","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1128\/JVI.03066-15","article-title":"Human cytomegalovirus-encoded human interleukin-10 (IL-10) homolog amplifies its immunomodulatory potential by upregulating human IL-10 in monocytes","volume":"90","author":"Avdic","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0190","first-page":"3217","article-title":"Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro","volume":"17","author":"Huettner","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02258360","article-title":"Activation of STAT transcription factors in oncogenic tyrosine kinase signaling","volume":"5","author":"Garcia","year":"1998","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0200","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)81959-5","article-title":"Stat3 as an oncogene","volume":"98","author":"Bromberg","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0205","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/nm1325","article-title":"Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity","volume":"11","author":"Kortylewski","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0210","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1128\/JVI.76.3.1285-1292.2002","article-title":"Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10","volume":"76","author":"Spencer","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0215","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/1078-0432.CCR-12-3314","article-title":"Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages","volume":"19","author":"Bloch","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.2370","article-title":"Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas","volume":"216","author":"Komohara","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0225","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00262-009-0667-x","article-title":"Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta","volume":"58","author":"Nagai","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0230","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/386510a0","article-title":"Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo","volume":"386","author":"Farrell","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0235","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/12478","article-title":"Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells","volume":"5","author":"Tomazin","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0240","doi-asserted-by":"crossref","first-page":"10929","DOI":"10.1128\/JVI.76.21.10929-10941.2002","article-title":"Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation","volume":"76","author":"Hegde","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0245","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1182\/blood-2002-05-1504","article-title":"Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain","volume":"101","author":"Odeberg","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0250","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/neuonc\/nor227","article-title":"Consensus on the role of human cytomegalovirus in glioblastoma","volume":"14","author":"Dziurzynski","year":"2012","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0255","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMc1302145","article-title":"Survival in patients with glioblastoma receiving valganciclovir","volume":"369","author":"Soderberg-Naucler","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0260","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ijc.28663","article-title":"Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir","volume":"135","author":"Soderberg-Naucler","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbcan.2017.05.006_bb0265","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1158\/1078-0432.CCR-13-1121","article-title":"Cidofovir: a novel antitumor agent for glioblastoma","volume":"19","author":"Hadaczek","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0270","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/CJI.0b013e318247642f","article-title":"Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma","volume":"35","author":"Ghazi","year":"2012","journal-title":"J. Immunother."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0275","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1158\/1078-0432.CCR-13-3268","article-title":"Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells","volume":"20","author":"Nair","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0280","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/icb.2012.19","article-title":"Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme","volume":"90","author":"Crough","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0285","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1158\/0008-5472.CAN-14-0296","article-title":"Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma","volume":"74","author":"Schuessler","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2017.05.006_bb0290","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1158\/1078-0432.CCR-16-2057","article-title":"Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination","volume":"23","author":"Batich","year":"2017","journal-title":"Clin. Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X17300318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X17300318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T02:08:36Z","timestamp":1569377316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X17300318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0304419X17300318"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.05.006","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}